I agree with you that on the surface the statement below seems rather innocuous. The problem is narrowing the event to fall under the definition of "fail to engraft." Again, these patients a horrifically ill. If the patient died, post transplant it's a safe bet that an attorney would attempt to tie the event and the guarantee to CBAI. If the patient did OK with a few complications I wouldn't put it past a few patients with thousands upon thousands of debt to pursue. Who could blame them as they are truly desperate? IMHO it would take 50K in lawyers fees to dismiss any claim that would be filed against CBAI in reference to a failed stem cell transplant OR CBAI opens itself up to greater legal exposure. There must be some legal minds on the board??? What say you?
Corcell is offering the best possible solution immediatedly following the slim chance the stem fails: Money.
Market Data 
Markets 
AI
